Reshape Lifesciences Received $331,541 Small Business Innovation Research Grant To Develop Its Diabetes Bloc-Stim Neuromodulation Device, Which Utilizes Its Vagus Nerve Block Technology, Combined With Vagus Nerve Stimulation, For Type 2 Diabetes
Portfolio Pulse from Benzinga Newsdesk
Reshape Lifesciences has been awarded a $331,541 Small Business Innovation Research Grant to develop its Diabetes Bloc-Stim Neuromodulation device. The device uses the company's Vagus Nerve Block technology in combination with Vagus Nerve Stimulation for the treatment of Type 2 Diabetes.
September 14, 2023 | 12:34 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
The grant received by Reshape Lifesciences for the development of its Diabetes Bloc-Stim Neuromodulation device could potentially boost the company's research and development efforts, and may have a positive impact on its stock.
The grant will provide financial support for the development of Reshape Lifesciences' Diabetes Bloc-Stim Neuromodulation device. This could potentially lead to advancements in the treatment of Type 2 Diabetes, which could increase the company's market share and profitability, thereby positively impacting its stock price.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100